Audio

January 9, 2010
 
Peter Pitts discusses the health care reform debate and President Barack Obama’s push to secure Congressional passage of a final bill.
 
Guests:
 
Peter Pitts
, president of the Center for Medicine in the Public Interest

Listen to the interview here
  • Peter Pitts and Canadian patient Shona Holmes appeared on “The John Steigerwald Show” on KDKA Radio in Pittsburghto discuss government-run health care
August 11, 2008
 
Shona Holmes shares her personal experience with the Canadian government-run health system and Peter Pitts discusses the inherent deficiencies of Canada’s system. They also take questions from callers.
 
Guests:
 
Peter Pitts
, president of the Center for Medicine in the Public Interest
Shona Holmes, Canadian patient and brain-tumor survivor

Listen to the interview here
Peter Pitts and Canadian patient Shona Holmes appeared on “The Laura Ingraham Show” to discuss the failure of government-run health care
 
July 7, 2008
 
Think Government-Run Health Care is a Good Idea? Think again. Closing out today’s show, Shona Holmes, a Canadian brain-tumor survivor, recounted her personal health-care horror story. Fortunately, she managed to flee to the States for a life-saving operation.
 
Guests:
 
Peter Pitts
, president of the Center for Medicine in the Public Interest
Shona Holmes, Canadian patient and brain-tumor survivor

Listen to the interview here
Peter Pitts appears on NPR’s “The Infinite Mind” in an episode entitled “Prozac Nation: Revisited”
 
March 26, 2008

In the wake of new high-profile violent acts by people taking anti-depressant medications, including the recent Northern Illinois University shootings, and new research on antidepressant medications and their possible link to “suicidality,” we look at the science on the connection between antidepressants and violent behavior. Is there a link between antidepressants and suicide? The answer may surprise you. 
 
Guests:

Nada Stotland
, president of the American Psychiatric Association
Peter Pitts, a former FDA official who participated in the administration’s labeling of antidepressants as dangerous, who is now director of the Center for Medicine in the Public Interest and a public relations consultant to pharmaceutical companies
Andrew Leuchter, director of the Laboratory of Brain, Behavior, and Pharmacology and Senior Research Scientist at UCLA, who has studied how press coverage and public alarm about antidepressants affects the nation’s health and willingness to be treated for real, life threatening illnesses

Listen to the interview here

 Pharmaceutical DTC Advertising interview - Dr. Jarvik advertisement
Sign Up for Our Email Newsletter

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington....  Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub...  Read more

Tort bar’s newest collateral damage: Preterm babies

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers...  Read more

DRUGWONKS BLOG